|
Match
|
Document |
Document Title |
|
|
4800198 |
Method of inducing the differentiation of malignant cells with secosterol
The invention provides a method for inducing the differentiation of malignant cells utilizing certain seco-sterol compounds, such as the differentiation of leukemia cells to normal macrophages and...
|
|
|
4749710 |
Immunosuppressive agents
The invention relates to pharmaceutical compositions comprising at least one Vitamin D derivative and a method of using the pharmaceutical compositions in suppressing immune responses.
|
|
|
4743442 |
Skin care composition
Skin care composition containing mineral salts releasing sodium, potassium, megnesium, calcium and zinc salts in defined concentration, and, optionally, compounds releasing copper, manganese,...
|
|
|
4740432 |
Vegetable origin fatty substance composition and cosmetic compositions containing the same
Vegetable fatty substance composition for use in cosmetics containing: fatty acid triglycerides 85-94%, fatty acid esters containing 40 carbon atoms 7-14%, vitamins 0.01-1.0%, antioxidant 0.5-1.5%...
|
|
|
4732759 |
Bath preparations and method for producing the same
A bath preparations comprise a cyclodextrin clathrate compound of vitamin, saccharifying enzyme and other materials of baths. The vitamin may be selected from the group consisting of vitamin A,...
|
|
|
4729895 |
Composition for solid pharmaceutical preparations of active vitamins D.sub. 3
This invention is concerned with a composition for solid pharmaceutical preparations of active vitamins D 3 , having the remarkably improved stability of active vitamins D 3 , and an extremely...
|
|
|
4725427 |
Effervescent vitamin-mineral granule preparation
Flavored, effervescent, water soluble compositions containing water-soluble and oil-soluble vitamins and amino acid chelated minerals in bioavailable form are contained in a composition consisting...
|
|
|
4719205 |
Side-chain unsaturated 1-hydroxyvitamin D compounds
Novel 1-hydroxylated vitamin D compounds containing a 22, 23-cis double bond in the side chain are provided. The compounds are characterized by an unexpectedly high binding affinity for the protein...
|
|
|
4719204 |
Fowl bone mineralization with 28-NOR 1α-hydroxyvitamin D.sub.2 analogs
The invention provides, as novel vitamin D derivatives, analogs of vitamin D 2 compounds which lack the 24-methyl substituent and are identified as 1α-hydroxy-28-norvitamin D 2 and...
|
|
|
4717721 |
Sidechain homo-vitamin D compounds with preferential anti-cancer activity
This invention relates to a method for enhancing cell differentiation in malignant cells by exposing the cells to a 1α-hydroxylated vitamin D derivative characterized by a 17-side chain greater in...
|
|
|
4711881 |
1α,25-dihydroxy-26,27-dimethylcholecalciferol and its use in the treatment of calcium pathobolism
1α,25-Dihydroxy-26,27-dimethylcholecalciferol represented by formula: ##STR1## This compound is prepared by irradiating 26,27-dimethylcholesta-5,7-diene-1α,3β,25-triol with ultraviolet light,...
|
|
|
4689180 |
1α,25-dihydroxy-22Z-dehydroxyvitamin D compound
The invention provides a novel vitamin D derivative, 1α,25-dihydroxy-22Z-dehydrovitamin D 2 . The compound is characterized by unexpectedly high ability to raise serum calcium levels. The compound...
|
|
|
4670247 |
Process for preparing fat-soluble vitamin active beadlets
A process is described for the preparation of fat-soluble vitamin active beadlet compositions which exhibit superior stability when exposed to the feed pelleting process. The process includes...
|
|
|
4661294 |
Biologically active 1-thio derivatives of vitamin D
Novel synthetic derivatives of vitamin D compounds are disclosed as well as processes for their synthesis. The novel compounds are 1-alpha-thio and acylated, 1-beta-thio derivatives of vitamin D...
|
|
|
4652405 |
Synthesis of 1α,25-dihydroxy-24R-fluorocholecalciferol and 1α,25-dihydroxy-24S-fluorocholecalciferol
1α,25-Dihydroxy-24R-fluorocholecalciferol and 1α,25-dihydroxy-24S-fluorocholecalciferol, analogs of 1α,25-dihydroxy-cholecalciferol which is physiologically the most active metabolite of vitamin...
|
|
|
4628050 |
Antinephritic pharmaceutical composition containing 24, 25-dihydroxycholecalciferol as an active ingredient
Disclosed herein is a pharmaceutical composition in dosage unit form, which comprises a dosage effective for treating nephritic disease of a compound of 24,25-dihydroxycholecalciferol as an active...
|
|
|
4619920 |
26,26,26,27,27-pentafluoro-1α-hydroxy-27-methoxyvitamin D.sub.3
The invention provides a new derivative of vitamin D 3 , 26,26,26,27,27-pentafluoro-1α-hydroxy-27-methoxy-cholecalci
ferol and a process for preparing the same. The compound is characterized by...
|
|
|
4617297 |
Method of treating disease states by the administration of 1α,25,26-trihydroxycholecalciferol
The present invention relates to the method of treating disease states characterized by higher than normal levels of endogenously produced 1α,25 dihydroxy-cholecalciferol or conditions where there...
|
|
|
4617294 |
Animal feed supplement
Free flowing, substantially dust-free, dense granular amorphous precipitated silica having a principal particle size of between about 0.14 millimeters and about 0.84 millimeters are described. This...
|
|
|
4613594 |
Fluorinated vitamin D.sub.3 compounds
Novel hexafluoro-cholecalciferol compounds and processes for preparing such compounds are disclosed. Intermediates utilized in the preparation of such compounds and pharmaceutical preparations...
|
|
|
4612308 |
25,26-Dehydro-1α,23(S,R)-dihydroxycholecalciferol and its epimers
The syntheses of 25,26-dehydro-1α,23S-dihydroxycholecalciferol, 25,26-dehydro-1α,23R-dihydroxycholecalciferol, and the epimeric mixture thereof which are useful as differentiation inducing agents...
|
|
|
4608392 |
Method for producing a non greasy protective and emollient film on the skin
A composition for topical application to the skin contains, as a fatty product to provide a nongreasy protective and emollient film thereon, a polyether oligomer having the formula ##STR1## wherein...
|
|
|
4599330 |
Method of treating milk fever
The present invention relates to a method of preventing milk fever which comprises administering to a preparturient female ruminant an effective amount of...
|
|
|
4594340 |
25,26-dehydro-1α,24R-dihydroxycholecalciferol and 25,26-dehydro-1α,24S-dihydroxycholecalciferol and the epimeric mixture
The syntheses of 25,26-dehydro-1α,24R-dihydroxycholecalciferol and 25,26-dehydro-1α,24S-dihydroxycholecalciferol and the epimeric mixture which are useful as differentiation inducing agent and...
|
|
|
4590184 |
Antiosteoporotic pharmaceutical composition containing 24,25-dihydroxycholecalciferol as an active ingredient
Disclosed herein is a pharmaceutical composition in dosage unit form, which comprises a dosage effective for treating osteoporosis of a compound of 24,25-dihydroxycholecalciferol and a...
|
|
|
4572915 |
Clear micellized solutions of fat soluble essential nutrients
Micellized aqueous formulations for fat soluble vitamins, essential nutrients, herb oils and pharmaceutical agents are obtained by a process wherein the fat soluble vitamin, essential nutrient or...
|
|
|
4547364 |
Hair treatment product
A composition for use in removing chlorine from hair and a method for using the subject composition to remove chlorine from hair are provided. The subject composition preferably comprises ammonium...
|
|
|
4511564 |
Methods of controlling the concentration of calcium in the serum of warm-blooded animals and pharmaceutical compositions to be used therefor
The present invention relates to a method of controlling the concentration of calcium in the serum of warm-blooded animals characterized by the administration of a pharmaceutically effective amount...
|
|
|
4505906 |
Hydroxyvitamin D.sub.2 isomers
The invention provides, as novel vitamin D derivatives, isomers of 25-hydroxyvitamin D 2 and 1α,25-dihydroxyvitamin D 2 characterized by a double bond at the 23,24-position. The compounds are...
|
|
|
4501738 |
Pharmaceutical composition containing 24,25-dihydroxycholecalciferol as an active ingredient to treat pain, pyrexia or inflammatory diseases
Disclosed is a pharmaceutical composition in dosage unit form which comprises a dosage effective for the treatment of pains and pyrexia, hypertension, hypotension, hyperlipemia, inflammatory...
|
|
|
4495181 |
1,25-Dihydroxy-24-oxo-vitamin D.sub.3 and 1,23,25-trihydroxy-24-oxo-vitamin D.sub.3
Novel biologically active metabolites of vitamin D 3 , 1,23,25-trihydroxy-24-oxo-vitamin D 3 (1,23,25(OH) 3 -24-oxo-D 3 ); and 1,25,-Dihydroxy-24-oxo-vitamin D 3 (1,25(OH) 2 -24-oxo-D 3 ). Also...
|
|
|
4486435 |
Spray-dried vitamin powders using hydrophobic silica
Encapsulated vitamin powders coated with a hydrophobic silica have improved free-flowing properties making these powders more suitable for direct tableting preparation.
|
|
|
4481198 |
Vitamin D metabolism inhibitor
This invention provides a novel vitamin D derivative, namely a 24-oxime derivative of vitamin D 3 , and a process for its preparation. The compound of this invention is an effective inhibitor of...
|
|
|
4461766 |
Method for inducing molting in laying hens
The invention provides a method for inducing molting in egg-laying hens as a means for extending their productive egg-laying life by administering to the hens an effective amount of a side...
|
|
|
4442093 |
Method for administering 24,25-dihydroxycholecalciferol to persons suffering from hypercalcemia
Pharmaceutical composition in dosage unit form, comprising a therapeutically effective amount of 24,25-dihydroxycholecalciferol and a pharmaceutically acceptable carrier. The compound of...
|
|
|
4428946 |
Method of preventing milk fever in dairy cattle
A method for prophylactically treating dairy cattle for parturient paresis by administering to cattle vitamin D derivatives which are characterized by the presence of a hydroxyl group at at least...
|
|
|
4391802 |
Method of treating leukemia or leukemoid diseases
A method of leukemia or leukemoid disease treatment by administration of a vitamin D derivative with a hydroxyl group at 1α-position is disclosed. It is believed that the vitamin D derivative with...
|
|
|
4364941 |
Method for regulating bone metabolism of warm-blooded animals, and pharmaceutical compositions thereof
A method for regulating the bone metabolism of a warm-blooded animal, which comprises administering pharmaceutically effective amounts of 1α, 24-dihydroxycholecalciferol (1α, 24-DHCC) and...
|
|
|
4341774 |
Method for suppressing abnormal rise in immunological function and agent useful therefor
A method for suppressing abnormal rise in immunological function which often causes various types of autoimmune diseases, and an agent useful therefor are disclosed. The method is carried out by...
|
|
|
4340604 |
Method for inhibiting the lowering of immunological function and agent therefor
A method for inhibiting the lowering of immunological function of patients who are suffering from serious renal disorder such as chronic renal failure or uremia which comprises administering...
|
|
|
4335120 |
Administration of biologically active vitamin D.sub.3 and vitamin D.sub.2 materials
A process for administering biologically active vitamin D 3 and vitamin D 2 materials into the blood system of a subject by providing the biologically active vitamin D 3 or D 2 material to the...
|
|
|
4313942 |
Activated vitamin D rodenticides
The invention provides a method for chemically activating vitamin D compounds to obtain active rodenticidal preparations. The activated vitamin D preparation offers an effective and relatively...
|
|
|
4310522 |
Chicken feed composition
The administration of 25-hydroxycholecalciferol, 24,25-dihydroxycholecalciferol, 25,26-dihydroxycholecalciferol, 1,25-dihydroxycholecalciferol, 25-hydroxydihydrotachysterol 3 ,...
|
|
|
4308264 |
Stabilized, dilute aqueous preparation of 1α,25-dihydroxycholecalciferol for neonatal administration
1α,25-Dihydroxycholecalciferol, also known as 1α,25-dihydroxyvitamin D 3 , calcitriol or 1α,25(OH) 2 D 3 , occurs naturally in man as the active form of cholecalciferol or vitamin D 3 . The...
|
|
|
4248867 |
Stabilized oily preparation of 1α-hydroxy-vitamin D and method for manufacturing the same
A stabilized oily preparation of a 1α-hydroxy-vitamin D for oral administration comprising a 1α-hydroxy-vitamin D and, as oily diluent, a triglyceride of saturated middle chain fatty acid which...
|
|
|
4237125 |
1α-Hydroxy-24-dehydrovitamin .sub.3 pharmaceutical compositions and uses thereof
Novel 1α-hydroxy-24-dehydrovitamin D 3 and its hydroxyl-protected derivatives; novel 1α-hydroxy-24-dehydroprevitamin D 3 and its hydroxyl-protected derivatives; and novel...
|
|
|
4225596 |
Method for treating calcium imbalance and improving calcium absorption in mammals
A method for treating or preventing metabolic bone disease characterized by loss of bone mass and of improving the calcium balance and calcium absorption of mammals, particularly of women in the...
|
|
|
4211782 |
Pharmaceutical combination
Combinations comprising an anti-aggregatory substance together with one or more of an anti-oxidant and a thromboxane A 2 synthetase inhibitor are disclosed. Combinations are useful for the...
|
|
|
4199577 |
Novel 1α-hydroxy-24-oxovitamin D.sub.3, its preparing process and the novel precursors thereof
Novel 1α,3β-dihydroxy-24-oxocholesta-5,7-diene and the hydroxyl group-protected derivatives thereof. Said novel 1α-hydroxy-24-oxovitamin D 3 and said novel intermediates are also useful as the...
|
|
|
4164569 |
Stabilized soft gelatin capsule composition of 1 α-hydroxy-vitamin D
A soft gelatin capsule preparation of a 1α-hydroxy-vitamin D which contains sorbic acid or its salt and a process for preparing the preparation are disclosed. Sorbic acid or its salt which is...
|